SARTORIUS AG
· ISIN: DE0007165631
· EQS - Company News
Sartorius releases Annual Report for 2024
Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor
Smart tools for smart investors can be found in our Tools section
Corporate News SARTORIUS AG
In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
This might be interesting for you as well
17 February 2025 10:00AM
Sartorius releases Annual Report for 2024
Göttingen, Germany | February 17, 2025
Sartorius releases Annual Report for 2024
The life science group Sartorius today released its Annual Report for 2024. The document is available at the following link: https://ir-reports.sartorius.com/en/ag/fy-2024/
Financial calendar
March 27, 2025 Annual Shareholders’ Meeting
April 16, 2025...
SARTORIUS AG
07 February 2025 03:48PM
The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share
Göttingen, February 7, 2025
The Supervisory Board of Sartorius AG proposes
a dividend of 0.74 euros per preference share
The Supervisory Board of Sartorius AG resolved at its meeting today to approve the recommendation of the Executive Board to submit a proposal to the Annual General Meeting on March 27, 2025, to pay a dividend of 0.74 euros p...
SARTORIUS AG
28 January 2025 07:00AM
Sartorius closes fiscal 2024 with very good fourth quarter and positive trend; full-year guidance achieved
Göttingen, Germany | January 28, 2025
Sartorius closes fiscal 2024 with very good fourth quarter and positive trend; full-year guidance achieved
Preliminary business results for 2024: sales revenue at 3,381 million euros (+ 0.1 percent in constant currencies), underlying profit margin reaches 28.0 percent
Order intake + 10.8 percent, demand i...
SARTORIUS AG
06 December 2024 06:21PM
Michael Grosse to succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG
Göttingen, December 6, 2024
Michael Grosse to succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG
Grosse to take over as Group CEO on July 1, 2025
At its meeting today, the Supervisory Board of Sartorius AG appointed Dr. Michael Grosse Chief Executive Officer of Sartorius. He will take over this position on July 1, 2025, from D...
SARTORIUS AG
06 December 2024 06:17PM
Michael Grosse to become Chief Executive Officer of Sartorius AG
Disclosure of inside information according to Article 17 MAR
Michael Grosse to become Chief Executive Officer of Sartorius AG
At its meeting today, the Supervisory Board of Sartorius AG resolved to appoint Dr. Michael Grosse as member of the Executive Board and Chief Executive Officer of the company with effect from July 1, 2025, for a term of th...
SARTORIUS AG
17 October 2024 07:00AM
sales revenue almost at prior-year level; orders on the rise; robust profitability; increased cash flow
Göttingen, Germany | October 17, 2024
Nine-month results in line with expectations: sales revenue almost at prior-year level; orders on the rise; robust profitability; increased cash flow
Group sales revenue down only slightly by - 2.0 percent after nine months; order intake up 6.6 percent
Underlying EBITDA margin reaches 27.7 percent; further i...
SARTORIUS AG
18 July 2024 06:28PM
Moderately positive revenue development in the second quarter; demand recovery remains muted, full-year outlook deliberately more cautious; long-term trends remain positive
Göttingen, July 18, 2024
Half-year results: Moderately positive revenue development in the second quarter; demand recovery remains muted, full-year outlook deliberately more cautious; long-term trends remain positive
Sales revenue slightly down 2.2 percent after six months; growth of 3.6 percent in second quarter
Underlying EBITDA margin at a ...
SARTORIUS AG
18 July 2024 06:22PM
Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for H1 2024
Disclosure of inside information according to Article 17 MAR
Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for H1 2024
In a continuously very challenging and volatile market environment, the life science group Sartorius closed the first half of the year with a positive trend in sales revenue development. In view of t...
SARTORIUS AG
More SARTORIUS AG related information
| Type | Total | Last | Made by | Go to |
|---|---|---|---|---|
| Corporate Research | 0 | - | - | Corporate Research |
| Directors Dealings | 2 | 23rd July 2024 | Kappich, Dr. Lothar Ewald | DD |
| Short Seller (DE) | 1 | 7th December 2017 | AQR Capital Management, LLC | SSR (DE) |
| Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.
v.07062023 EN